This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03939364 |
|
Recruitment Status :
Withdrawn
(Delays due to manufacturing and the COVID-19 pandemic)
First Posted : May 6, 2019
Last Update Posted : October 19, 2021
|
Sponsor:
Skyline Biosciences
Information provided by (Responsible Party):
Skyline Biosciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | April 2023 |
| Estimated Study Completion Date : | May 2023 |